Prior to joining Cytokinetics, Dave served as Vice President of Research for Iconix Pharmaceuticals, Inc. from 1998 to 2000. From 1983 to 1998, he held various positions at Syntex and Roche Biosciences including the role of Vice President, Inflammatory Diseases at Roche Biosciences following the acquisition of Syntex. Prior to his tenure at Syntex and Roche Bioscience, David was an Assistant Professor of Chemistry at University of California, Santa Cruz. Dr. Morgans received a B.S. in Chemistry from Saint Joseph’s University in Philadelphia and a Ph.D. in Chemistry from Columbia University. |